Pouring Oil on Troubled Retinas
Silicone oil tamponades can inhibit scar tissue formation in patients with a high risk of retinal scarring after retinal detachment. But how much more effective would these products be, if they also delivered antifibrotics?
Victoria Kearns | | Longer Read
At a Glance
- Replacing the vitreous with silicone oil can reduce scar tissue formation in vitreoretinopathy and diabetic retinopathy, but attempts to combine the oil with pharmaceuticals have not yet been successful
- A multidisciplinary team at the University of Liverpool, UK, is working on achieving controlled drug release from silicone tamponades to prevent retinal scarring
- Milestones of the research so far include choosing the right model drug and determining its solubility in oil, as well as modulating the release kinetics of oil-drug combinations
- The team has proven that modified silicone oils are non-toxic to relevant cells, they enhance drug solubility and extend drug release.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine